𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prolongation of rat pancreatic islet allograft survival by treatment of recipient rats with monoclonal anti-interleukin-2 receptor antibody and cyclosporin

✍ Scribed by H. J. Hahn; B. Kuttler; A. Dunger; I. Klöting; S. Lucke; H. D. Volk; R. v. Baehr; T. Diamantstein

Publisher
Springer
Year
1987
Tongue
English
Weight
339 KB
Volume
30
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Curing BB rats of freshly manifested dia
Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A
✍ Hans J. Hahn; Silke Lucke; Ingrid Klöting; Hans D. Volk; Rüdiger V. Baehr; Tibor 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

## Curing BB rats of freshly manifested diabetes by shortterm treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A The BioBreeding (BB) rat develops spontaneously a syndrome resembling human type I diabetes mellitus. The short

Blocking of interleukin 2 (IL 2) binding
Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18
✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been